Израиль - иврит - Ministry of Health

sanofi - aventis israel ltd - aluminium oxide hydrated 200 mg; dimethicone 25 mg - chewable tablets - combinations - antacid, antiflatulent, relief of sensation of heartburn.

Израиль - иврит - Ministry of Health

sanofi - aventis israel ltd - aluminium oxide hydrated 460 mg; magnesium hydroxide 400 mg - suspension - combinations - for heartburn and gastroesophageal reflux.

Израиль - иврит - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Израиль - иврит - Ministry of Health

teva pharmaceutical indust.ltd - allantoin 2 %; aluminium acetotartrate 0.4 % - ointment - benzocaine - for the relief of pain and inflammation caused by hemorrhoids.

Израиль - иврит - Ministry of Health

perrigo israel agencies ltd - vinflunine ditartrate - תרכיז להכנת תמיסה לאינפוזיה - vinflunine ditartrate 25 mg/ml - vinflunine - vinflunine - javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinium-containing regimen. efficacy and safety of vinflunine have not been studied in patients with performance status ?2.

Израиль - иврит - Ministry of Health

j-c health care ltd - doxorubicin hydrochloride - liposome for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.

Израиль - иврит - Ministry of Health

לה קרים סופ בעמ - דאודורנט

Израиль - иврит - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - הבהרת השיער

Израиль - иврит - Ministry of Health

novartis israel ltd - indacaterol as maleate - אבקה לשאיפה בקפסולות קשיחות - indacaterol as maleate 150 mcg - indacaterol

Израиль - иврит - Ministry of Health

novartis israel ltd - indacaterol as maleate - אבקה לשאיפה בקפסולות קשיחות - indacaterol as maleate 300 mcg - indacaterol